News

Sleep Problems in Parkinson’s May Be Linked to Certain Medications

Sleep disturbances are common in people with diseases marked by alpha-synuclein buildup, but they are especially problematic among Parkinson’s disease patients on dopaminergic medications, a study suggests. Parkinson’s patients tend to have more arousals during sleep and fewer normal sleep cycles than people with isolated rapid eye movement (REM)…

New Genetic Mouse Model May Aid in Parkinson’s Research

A new Parkinson’s disease mouse model — carrying a common disease-associated mutation in both copies of the LRRK2 gene — recapitulates some motor and behavioral symptoms of the disease, while also showing mitochondrial abnormalities, a study showed. Problems in mitochondria, known as the powerhouses of the body’s cells, are increasingly seen…

Parkinson’s Foundation Awards 33 Grants Worth $5.7M

Note: This story was updated Aug. 18, 2022, to reflect researchers awarded The Stanley Fahn Junior Faculty Award will receive a total maximum grant of $300,000 over three years.  The Parkinson’s Foundation announced it is investing $5.7 million across 33 research grants as part of its commitment to speed innovative…

New Roadmap of Dopaminergic Neurons May Improve Cell Therapy

Scientists have created a roadmap of the maturation steps of dopaminergic neurons — the nerve cells progressively lost in Parkinson’s disease — from human stem cells. Their work may help identify potential ways to optimize this process in the lab for new Parkinson’s cell therapies. “Our findings provide valuable…

High Levels of Levodopa Found in Mucuna Pruriens Supplements

Very high levels of levodopa — a compound commonly prescribed to treat Parkinson’s disease — were detected in some over-the-counter supplements with extracts from Mucuna pruriens, a type of bean that naturally contains levodopa, a study has found. In many of the tested supplements, the amount of levodopa…

Exercise Eases Motor Symptoms in Parkinson’s Early-to-mid Stages

At least six months of physical therapy helps to ease motor symptoms, possibly allowing for lower medication doses among people with mild-to-moderate Parkinson’s disease, according to findings from a recent meta-analysis of published clinical trial data. Beneficial changes in Parkinson’s motor symptoms were observed regardless of whether patients…